Écrit par Novozymes | 25 Octobre 2012

COPENHAGEN, DENMARK - October 25, 2012 - Novozymes, the world leader in bioinnovation and industrial enzymes, today reported sales growth of 6% in DKK for the first 9 months of 2012. EBIT grew by 12% compared with the first 9 months of 2011, increasing the EBIT margin to 24.6%. The expectations for full-year 2012 EBIT growth, EBIT margin and net profit growth are maintained, as is the...

Écrit par Safe Orthopaedics | 24 Octobre 2012

DALLAS / Privately held Safe Orthopaedics aims to revolutionize the way orthopedic and spinal implant systems are delivered by introducing the SteriSpine™ PS Pedicle Screw system — the world’s first single-use, sterile and traceable system for fixation of the lumbar spine — at the North American Spine Society (NASS) Meeting in Dallas this October 24-27.

“The introduction of...

Écrit par DIA | 23 Octobre 2012

BEIJING, CHINA—OCTOBER 23, 2012— DIA, the premier organization dedicated to knowledge exchange that fosters innovation to raise the level of health and well-being worldwide will host the 2012 Statistical Workshop, two days focusing on understanding the statistical thinking in clinical research for drug development and control overall false positive rate in clinical trials to ensure...

Écrit par GlobalData | 22 Octobre 2012

LONDON, UK (GlobalData), 22 October 2012 - The 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) played host to promising data that aim to address one of the greatest unmet needs in Multiple Sclerosis (MS): the treatment for progressive forms of the disease. Although Primary-Progressive MS (PPMS) afflicts only 10%–15% of the MS...